GRGabrielle H. van Ramshorst

Gabrielle H. van Ramshorst

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gabrielle H. van Ramshorst has a total of 899 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • ASO Author Reflections: Para-aortic Lymph Node Metastasis in Colorectal Cancer

    by Andreas Denys, Amanda Verstraete, Karen Geboes, Gabrielle H. van Ramshorst

  • Global oncological surgery at a crossroads: Overcoming inequities and disparities through collective action and strategic vision

    by Rodrigo Nascimento Pinheiro, Domenico D'UGo, Felipe José Fernández Coimbra, Timothy M. Pawlik, Lucio Lara Santos, Joaquim Abreu Sousa, Jörg Kleeff, Nilton Caetano da Rosa, Delfina Irina Bernardo Jacinto, Gabrielle H. van Ramshorst, et al.

  • Development and Content Validation of a Belgian Patient Decision Aid for Surgical Decision-making in Rectal Cancer: A Double-modified Delphi Study

    by Isabel Vlerick, Gabriëlle H. van Ramshorst, Dirk Van de Putte, Karen Geboes, Wim Ceelen, Ann Van Hecke, Yves Van Nieuwenhove, Eva Pape

  • Low anterior resection syndrome and bowel dysfunction after ovarian cancer cytoreductive surgery: a narrative review

    by David Viveros-Carreño, Nathalia Mora-Soto, Isabel Beshar, Martina A. Angeles, Vicente Bebia, Ana Luzarraga Aznar, Naia Seminario, Gabrielle H. van Ramshorst, Alejandro Rauh-Hain, René Pareja

  • Experiences of LGB patients undergoing colorectal cancer surgery: A focus on sexuality

    by Anna Provoost, Louis Onghena, Khushi Jeswani, Yves van Nieuwenhove, Eva Pape, Gabrielle H. van Ramshorst

    Purpose: This study aimed to delineate the existing knowledge regarding the impact of colorectal cancer surgery on the sexuality of LGB patients, highlighting the need for culturally competent care tailored to their unique needs. Methods: A comprehensive search was conducted from October 2024 onwards across PubMed, Embase, CINAHL, Google Scholar, Web of Science, Scopus, PsychINFO, Cochrane Library, and Joanna Briggs Institute using the MeSH terms ‘sexual and gender minorities’, ‘colorectal surgery’, ‘colorectal neoplasms’ and ‘sexuality’. Inclusion criteria required LGB patients over 18 years, at least 50% of the sample diagnosed with colorectal cancer and treated operatively. All studies were critically appraised. Results: Six studies from the UK and the US were included. Sample size ranged from 1 to 480. Participants identifying as LGB ranged from 26.4 to 100%. Key findings revealed LGB patients experience similar physical consequences to heterosexual patients (erectile and ejaculatory dysfunction, dyspareunia, vaginal dryness), but implications might differ, e.g., regarding anal intercourse. A lower mental quality of life was reported, including body image issues related to stomas. Relationship challenges and intimacy issues were highlighted. The cultural competence of healthcare providers has a significant influence on patient experiences, highlighting a gap in inclusive care. Critical appraisal revealed both methodological strengths and weaknesses. Conclusion: This review highlighted the sexual health challenges of LGB patients after colorectal cancer surgery, with issues like sexual function and mental wellbeing often being underreported. Cultural competence training for healthcare providers and integrating patients' partners into cancer care are crucial for a holistic approach.

  • Open Access

    Complications and recurrence after pelvic exenteration for gynecologic malignancies: Analysis of surgical complications from the COREPEX study

    by Nicolò Bizzarri, Denis Querleu, Giulio Ricotta, Diana Giannarelli, Mihai Emil Cãpîlna, Santiago Domingo, Vito Chiantera, Hüseyin Akıllı, David Cibula, Zoltan Novák, et al.


  • Results of the international audit for faecal incontinence on behalf of the European Society of Coloproctology (ESCP) collaborating group

    by Audrius Dulskas, Dovile Cerkauskaite, Alaa El‐Hussuna, Gaetano Gallo, Dragomir Dardanov, Saulius Svagzdys, Baljit Singh, Thomas Pinkney, Gianluca Pellino, James Glasbey, et al.

    Aim: The aim of this study was to evaluate the prevalence of faecal incontinence (FI) among patients attending colorectal clinics in a global setting, treatment choices and accessibility to diagnostic and treatment tools. Methods: An international, prospective, multi‐centre snapshot audit and survey of patients undergoing consultation regarding FI was undertaken from January 9 to February 28, 2023. Participating units included patients in the audit who presented until March 28, 2023. Main outcomes measured included the prevalence of FI in clinical practice, diagnostic approaches, treatment patterns and availability of interventions. Results: A total of 1853 outpatients with FI and 363 surgical patients were included, representing a prevalence of 6.3% of total clinic attendance over the same period. The majority of patients were female (75.3%), parous (85% of females). Patients presented with passive and urge incontinence, or both, in fairly even proportions (34.8 vs. 29.4 vs. 33.7%, respectively). Aetiology was most commonly anal injury (surgical or obstetric: 15.4% vs. 19.8%, respectively), but with significant proportions of other surgical conditions, such as low anterior resection syndrome (11.1%) and rectal prolapse (12.7%). In the surgical audit ( n = 363), the majority of patients had received previous treatment (61.1%), including pelvic floor physiotherapy (67.1%), bowel retraining with biofeedback (51.4%), and nurse‐led continence support (40.5%). Of 395 procedures performed, sacral neuromodulation was the most common (28.9%), followed by sphincteroplasty (22.0%). In the global practice survey ( n = 250 respondents), endoanal ultrasound (EAUS) (82.4%) and anorectal manometry (74.4%) were the most available diagnostic tools. Conclusions: Globally, FI forms a significant part of colorectal surgeons' clinical workload, with a skew toward structural causes of FI. Practice varies according to the availability of diagnostics and procedures.


  • Incisional and parastomal hernias after harvesting of Vertical Rectus Abdominis Myocutaneous (VRAM) flaps: incidence, treatment options and outcomes

    by Camille Vervaet, Camille Maeyaert, Mathias Allaeys, Frederik Berrevoet, Hasan H. Eker, Gabrielle H. van Ramshorst

    The Vertical Rectus Abdominis Myocutaneous (VRAM) flap is a versatile reconstructive technique but is associated with donor-site morbidity, including incisional hernia (IH) and parastomal hernia (PSH). Our aim was to assess the incidence, treatment options and outcomes of IH and PSH following VRAM flap harvest. A systematic search was conducted in PubMed, Embase and Scopus (to June 2024) using predefined terms. Studies with at least 10 participants and a follow-up of minimum one year were included. Two reviewers independently performed study selection, data extraction, quality of evidence (GRADE) and risk of bias (ROBINS-I, RoB-2). Primary outcomes were IH and PSH incidence. 24 studies (2200 patients) were included (19 retrospective cohorts, 3 case series, 2 randomized controlled trials). IH was reported in 10.2% (226/2200) and PSH in 19.2% (219/1143) of patients over a mean follow-up of 31 months (range: 12-66). Studies focused on prophylactic techniques included robotic harvesting (n = 1), fascia-sparing harvesting (n = 5), component separation (n = 6) and mesh-assisted closure (n = 16). Hernia repair involved mesh (n = 3) and primary suture (n = 1). Despite advances in prophylactic techniques for hernia prevention, significant challenges remain, including high heterogeneity in clinical diagnosis, follow-up duration, and surgical techniques. While some methods, such as fascia-sparing approaches, component separation, and mesh reinforcement show promising outcomes in reducing IH and PSH incidence, a lack of comparative studies prevents reaching a clear consensus. Future research should focus on larger scale studies and expert opinions to develop clinical recommendations for hernia prophylaxis and repair.


  • Ligation of the intersphincteric fistula tract (LIFT) in complex anorectal fistulas: retrospective analysis of the outcomes in a tertiary hospital

    by Dirk Van De Putte, Martijn Depuydt, Jan Colpaert, Gabrielle H. Van Ramshorst

    Anal fistula treatment remains a surgical challenge. This study focuses on the efficiency and safety of the Ligation of Intersphincteric Fistula Tract (LIFT) procedure for high intersphincteric anorectal fistulas, aiming to identify prognostic factors for success and complications. A retrospective chart review was conducted on all patients who underwent LIFT procedure at a tertiary referral hospital between January 2013 and January 2021. The primary endpoint was the success rate of fistula closure, confirmed with clinical investigation. Secondary endpoints included postoperative complications, reintervention and self-reported incontinence. Logistic regression analyses were performed for assessing prognostic factors for fistula closure and postoperative complications. Ninety-two patients were included in the study; after a median follow-up of 19.3 months, fistula closure was achieved in 71% (n = 65) and in 89% (n = 82) after reinterventions. 46% (n = 42) reported persistent symptoms, although 83% of which (n = 32/42) had succesful fistula tract closure by clinical evaluation. One patient developed incontinency for gas. Smoking emerged as a significant risk factor for fistula closure failure, OR = 6.75, 95% CI = [1.65, 27.69], p = 0.030. Wound dehiscence was the most common complication, occuring in 25% (n = 23). Prolonged oral antibiotics demonstrated a significant protective effect against wound dehiscence, OR = 0.31, 95% CI = [0.10, 0.96], p = 0.036. The LIFT procedure is an efficient and safe treatment for complex perianal fistula. Patient satisfaction emerged as a crucial treatment goal, as patients can remain symptomatic after fistula closure. Emphasizing smoking cessation is integral to the treatment approach. The findings suggest prolonged antibiotic treatment as a potential preventive measure for wound dehiscence.